Health ❯Healthcare ❯Obesity

Weight Management

GLP-1 Drugs Prescription Medications Semaglutide for Weight Loss Medications Medication Management Hormonal Treatments Medication Efficacy Tirzepatide Semaglutide Effects Weight Loss Medications

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

The analysis underscores the importance of extended anti-obesity treatment with integrated lifestyle support to prevent rebound weight gain.

Intermittent Energy Restriction Shows Greatest Benefits in Diabetes Weight-Loss Trial

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Novo Nordisk’s Amycretin Delivers Up to 24% Early Weight Loss in Dual-Form Trials

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

UK Regulators Warn Against Misuse of Weight-Loss Injections

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Weight-Loss Drug Tirzepatide More Effective in Women, Study Finds

NHS 'Soup and Shake' Diet Shows Promise in Reversing Type 2 Diabetes

Semaglutide Drugs Show Potential Beyond Weight Loss